REGiMMUNE’s mission is to use immune-regulating technology to develop novel therapeutics for a range of immune diseases and disorders. We honor the interests of our potential patients, our employees, our investors and our communities with a great sense of responsibility and ethics.
Our business strategy is to develop novel and proprietary products focused on therapeutic areas that can be addressed with immune-regulating technology. We expedite programs by actively using outside resources and partnering with biotechnology and pharmaceutical companies to leverage technology assets. While we have a clear vision for the company, our approach is flexible, which drives our growth and promotes success.